Home
About
Publications Trends
Recent Publications
Expert Search
Archive
change in bowel habits
How Are These Changes Linked to Cancer?
Changes in bowel habits can be a symptom of different types of cancer, including:
Colorectal cancer
Anal cancer
Stomach cancer
Pancreatic cancer
These cancers can cause physical changes in the intestines or digestive tract that lead to alterations in bowel habits. For instance, a tumor in the colon may partially block the passage of stool, causing constipation or narrow stools.
Frequently asked queries:
What Are Bowel Habits?
Why Is a Change in Bowel Habits Concerning?
What Types of Changes Should Be Watched?
How Are These Changes Linked to Cancer?
What Tests Might Be Conducted?
Why is p53 Important in Cancer?
What are the Limitations of PD-L1 as a Biomarker?
What are the Risks and Benefits of Cancer Surgery?
What is Hydromorphone?
What Services Do Local Governments Provide for Cancer Patients?
Why is the Charlson Comorbidity Index Important in Cancer Care?
What Role Do Biomarkers Play in Predictive Oncology?
How Can Individuals and Organizations Get Involved?
What is Data Fragmentation in Cancer Research?
How Can Delays Be Minimized?
How are Cancer Emergencies Diagnosed?
What is NCRP Report No. 116?
How Do Patents Affect Collaboration in Cancer Research?
What Challenges are Associated with X-Ray Crystallography in Cancer Research?
What is Minimally Invasive Surgery?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Lung Cancer
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
Keratinocyte
Lipid-based nanoparticles
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe